Urine metabolomics as a predictor of patient tolerance and response to adjuvant chemotherapy in colorectal cancer.

Urine metabolomics as a predictor of patient tolerance and response to adjuvant chemotherapy in colorectal cancer. — المؤلف: Dykstra, Mark A — Molecular and clinical oncology Nov 2017

المؤلف
Dykstra, Mark A
النشر
Molecular and clinical oncology Nov 2017
الوصف
767-770 p.